期刊文献+

不同剂量秋水仙碱在痛风急性发作期治疗中的疗效分析 被引量:8

Analysis on curative effect of different doses of colchicine in the treatment of acute attack of gout
下载PDF
导出
摘要 目的对比研究不同剂量秋水仙碱用于痛风急性发作期的治疗效果。方法 141例痛风急性发作期患者,均采用秋水仙碱治疗,根据剂量不同分为低剂量组、中剂量组和高剂量组,每组47例。比较三组的治疗效果。结果低剂量组总有效率为82.9%、中剂量组总有效率为89.36%、高剂量组总有效率为93.62%,三组两两比较,差异均无统计学意义(P>0.05)。低剂量组不良反应发生率12.77%与中剂量组不良反应发生率27.66%均低于高剂量组74.47%,差异均具有统计学意义(P<0.05);低剂量组不良反应发生率低于中剂量组但差异无统计学意义(P>0.05)。结论低、中、高三种剂量秋水仙碱在治疗痛风急性发作期时,疗效相当,但低剂量在减少不良反应方面,更具优势。 Objective To compare and study the treatment effect of different doses of colchicineapplied in acute attack of gout.Methods A total of141acute attack of gout patients all receiving colchicinefor treatment were divided by different doses into low-dose group,medium-dose group and high-dose group,with47cases in each group.Treatment effect was compared in three groups.Results Low-dose group had totaleffective rate as82.9%,medium-dose group had total effective rate as89.36%,and high-dose group had totaleffective rate as93.62%.There was no statistically significant difference in pairwise comparison of three groups(P>0.05).Low-dose group had incidence of adverse reactions as12.77%,and medium-group had incidence ofadverse reactions as27.66%,which were all higher than74.47%in high-dose group,and their difference hadstatistical significance(P<0.05).Low-dose group had lower incidence of adverse reactions than medium-dosegroup,but their difference had no statistical significance(P>0.05).Conclusion Low,medium and high dosesof colchicine shows equal curative effect in treating acute attack of gout,but low doses has more advantages inreducing adverse reactions.
作者 钟志华 黄启亚 罗成建 ZHONG Zhi-hua;HUANG Qi-ya;LUO Cheng-jian(Guangzhou Medical University Affiliated Sixth Hospital,Guangzhou 511500, China)
出处 《中国现代药物应用》 2017年第9期65-66,共2页 Chinese Journal of Modern Drug Application
关键词 痛风急性发作期 秋水仙碱 剂量 安全性 Acute attack of gout Colchicine Doses Safety
  • 相关文献

参考文献10

二级参考文献94

  • 1赵家敏.不同剂量秋水仙碱治疗急性痛风性关节炎疗效观察[J].中国实用乡村医生杂志,2005,12(1):35-35. 被引量:5
  • 2潘碧琦,陈磊,刘军.中西医结合治疗痛风疗效观察[J].中医药学刊,2006,24(6):1178-1179. 被引量:7
  • 3牛文凯,邱泽武.秋水仙碱中毒的诊断与处理[J].药物不良反应杂志,2006,8(5):368-369. 被引量:38
  • 4孟昭亨.痛风[M].北京:北京医科大学、中国协和医科大学联合出版社,1998.90.
  • 5陈新谦,金有豫,汤光.新编药物学[M].北京:人民卫生出版社,2011:609-621.
  • 6Zhang W, Doherty M, Bardin T, et al. EULAR evidence based recommendations for gout. Part Ⅱ: management. Report of a task force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT). Ann Rheum Dis, 2006,65(10) : 1312-1324.
  • 7Wallace SL, Robinson H, Masi AT, et al. Preliminary criteria for the classification of the acute arthritis of primary gout. Arthritis Rheum, 1977, 20(3) : 895-900.
  • 8Harden N, Cohen M. Unmet needs in the management of neuropathie pain. J Pain Symptom Manage, 2003,25 Suppl:S12- 17.
  • 9Terkehaub RA, Furst DE, Bennett K, et al. High versus low dosing of oral colchicine for early acute gout flare: twenty-four-hour outcome of the first muhicenter, randomized, double-blind, placebo-controlled, parallel-group, dose-comparison colehicine study. Arthritis Rheum, 2010, 62 ( 4 ) : 1060-1068.
  • 10Suresh E, Das P. Recent advances in management of gout [ J ]. QJM ,2012,105 ( 5 ) :407-417.

共引文献120

同被引文献77

引证文献8

二级引证文献38

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部